As of 2024-12-15, the EV/EBITDA ratio of Theradiag SA (ALTER.PA) is
22.48.
EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ALTER.PA's latest enterprise value
is 12.36 mil EUR. ALTER.PA's TTM EBITDA according to its financial statements is
0.55 mil EUR. Dividing these 2
quantities gives us the above ALTER.PA EV/EBITDA ratio.
|
Range |
Selected |
| Trailing P/E multiples |
11.6x - 16.6x |
14.2x |
| Forward P/E multiples |
9.4x - 13.0x |
10.7x |
| Fair Price |
0.71 - 1.01 |
0.84 |
| Upside |
-43.9% - -19.6% |
-33.5% |